Raymond T. Keane

Insider Reports History

Entity
Individual
Location
C/O Ariad Pharmaceuticals, Inc., 26 Landsdowne Street, Cambridge, MA
Signature
/s/ Jeffrey Trigilio, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Raymond T. Keane:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cullinan Oncology, Inc. Chief Legal Officer Common Stock 24.1K $301K $12.46 Feb 11, 2022 Direct
Cullinan Oncology, Inc. Chief Legal Officer Stock Option (Right to Buy) 45K Feb 11, 2022 Direct

Insider Reports Filed by Raymond T. Keane

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CGEM Cullinan Oncology, Inc. Feb 11, 2022 2 $0 4 Feb 15, 2022 Chief Legal Officer